NS
NVCR icon

NBC Securities’s NovoCure NVCR Stock Holding History

NBC Securities’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37
Closed -$1K – 2167
2024
Q1 		$1K Buy
+37
New +$544 ﹤0.01% 2111
2023
Q4 		– Sell
-44
Closed – – 2199
2023
Q3 		$0 Buy
+44
New +$1.27K ﹤0.01% 2156

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

NBC Securities's NVCR Position: Q2 2024 in Review

NBC Securities sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 37 shares — an estimated $1K sold.

NBC Securities first reported a position in NVCR in Q3 2023 and held it in 2 quarters. The position peaked at $1K in Q1 2024. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • NBC Securities reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
  • NBC Securities sold 37 NovoCure shares in Q2 2024, an estimated $1K.
  • NBC Securities first reported a position in NovoCure in Q3 2023 and held it in 2 quarters.
  • NBC Securities's NovoCure position peaked at $1K in Q1 2024.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on NBC Securities's 13F filing for Q2 2024, filed 10 Jul 2024.